NM_005356.5:c.134G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005356.5(LCK):​c.134G>A​(p.Arg45Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00436 in 1,607,346 control chromosomes in the GnomAD database, including 456 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 118 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 338 hom. )

Consequence

LCK
NM_005356.5 missense

Scores

4
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.32

Publications

6 publications found
Variant links:
Genes affected
LCK (HGNC:6524): (LCK proto-oncogene, Src family tyrosine kinase) This gene is a member of the Src family of protein tyrosine kinases (PTKs). The encoded protein is a key signaling molecule in the selection and maturation of developing T-cells. It contains N-terminal sites for myristylation and palmitylation, a PTK domain, and SH2 and SH3 domains which are involved in mediating protein-protein interactions with phosphotyrosine-containing and proline-rich motifs, respectively. The protein localizes to the plasma membrane and pericentrosomal vesicles, and binds to cell surface receptors, including CD4 and CD8, and other signaling molecules. Multiple alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Aug 2016]
LCK Gene-Disease associations (from GenCC):
  • severe combined immunodeficiency due to LCK deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0014267564).
BP6
Variant 1-32274765-G-A is Benign according to our data. Variant chr1-32274765-G-A is described in ClinVar as Benign. ClinVar VariationId is 474985.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.098 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LCKNM_005356.5 linkc.134G>A p.Arg45Gln missense_variant Exon 3 of 13 ENST00000336890.10 NP_005347.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LCKENST00000336890.10 linkc.134G>A p.Arg45Gln missense_variant Exon 3 of 13 1 NM_005356.5 ENSP00000337825.5

Frequencies

GnomAD3 genomes
AF:
0.0111
AC:
1683
AN:
152024
Hom.:
115
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00198
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.101
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.0234
GnomAD2 exomes
AF:
0.0155
AC:
3821
AN:
246356
AF XY:
0.0119
show subpopulations
Gnomad AFR exome
AF:
0.00179
Gnomad AMR exome
AF:
0.108
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000359
Gnomad OTH exome
AF:
0.0143
GnomAD4 exome
AF:
0.00365
AC:
5313
AN:
1455204
Hom.:
338
Cov.:
32
AF XY:
0.00315
AC XY:
2281
AN XY:
723146
show subpopulations
African (AFR)
AF:
0.00141
AC:
47
AN:
33398
American (AMR)
AF:
0.111
AC:
4915
AN:
44378
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25532
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39630
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85232
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53158
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5736
European-Non Finnish (NFE)
AF:
0.0000244
AC:
27
AN:
1108022
Other (OTH)
AF:
0.00537
AC:
323
AN:
60118
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
291
583
874
1166
1457
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0112
AC:
1699
AN:
152142
Hom.:
118
Cov.:
32
AF XY:
0.0126
AC XY:
938
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.00198
AC:
82
AN:
41500
American (AMR)
AF:
0.102
AC:
1561
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68008
Other (OTH)
AF:
0.0232
AC:
49
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
74
149
223
298
372
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00220
Hom.:
17
Bravo
AF:
0.0186
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.0111
AC:
1353
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 22% of patients studied by a panel of primary immunodeficiencies. Number of patients: 21. Only high quality variants are reported.

Severe combined immunodeficiency due to LCK deficiency Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.24
T;T;.;T;T;.;T;T;.;.
Eigen
Benign
-0.34
Eigen_PC
Benign
-0.17
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.91
D;.;D;D;D;D;D;D;D;D
MetaRNN
Benign
0.0014
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
.;L;.;.;L;.;.;.;.;L
PhyloP100
2.3
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-0.31
N;N;N;N;.;N;N;N;N;N
REVEL
Benign
0.093
Sift
Benign
0.16
T;T;T;T;.;T;T;D;T;T
Sift4G
Benign
0.62
T;T;T;T;T;T;T;D;T;T
Vest4
0.26
ClinPred
0.0094
T
GERP RS
3.7
Varity_R
0.080
gMVP
0.38
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145088108; hg19: chr1-32740366; API